1-5 of 5
Courtney D. DiNardo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Venetoclax-Based Combination Regimens in Acute Myeloid Leukemia

Hannah Goulart, Hagop Kantarjian, Naveen Pemmaraju, Naval Daver, Courtney D. DiNardo, Caitlin R. Rausch, Farhad Ravandi, Tapan M. Kadia
Journal: Blood Cancer Discovery
Blood Cancer Discov (2025) 6 (1): 23–37.
https://doi.org/10.1158/2643-3230.BCD-24-0171
Published: 08 January 2025
View article titled, Venetoclax-Based Combination Regimens in Acute Myeloid Leukemia
Open the PDF for Venetoclax-Based Combination Regimens in Acute Myeloid Leukemia in another window
Journal Articles

Abstract P14: Efficacy of FHD-286 monotherapy and combinations against Menin inhibitor sensitive and resistant AML cells

Warren C Fiskus, Jessica Piel, Murphy Hentemann, Mike Collins, Christopher P Mill, Branko Cuglievan, Courtney D DiNardo, Kapil N Bhalla
Journal: Blood Cancer Discovery
Blood Cancer Discov (2024) 5 (2_Supplement): P14.
https://doi.org/10.1158/2643-3249.BCDSYMP24-P14
Published: 04 March 2024
View article titled, Abstract P14: Efficacy of FHD-286 monotherapy and combinations against Menin inhibitor sensitive and resistant AML cells
Journal Articles

A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1-Mutated Myeloid Malignancies

Curtis A. Lachowiez, Sanam Loghavi, Zhihong Zeng, Tomoyuki Tanaka, Yi June Kim, Hidetaka Uryu, Sven Turkalj, Niels Asger Jakobsen, Marlise R. Luskin, Dzifa Y. Duose, Rebecca S.S. Tidwell, Nicholas J. Short, Gautam Borthakur, Tapan M. Kadia, Lucia Masarova, George D. Tippett, Prithviraj Bose, Elias J. Jabbour, Farhad Ravandi, Naval G. Daver, Guillermo Garcia-Manero, Hagop Kantarjian, Jacqueline S. Garcia, Paresh Vyas, Koichi Takahashi, Marina Konopleva, Courtney D. DiNardo
Journal: Blood Cancer Discovery
Blood Cancer Discov (2023) 4 (4): 276–293.
https://doi.org/10.1158/2643-3230.BCD-22-0205
Published: 05 July 2023
View article titled, A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in <em>IDH1</em>-Mutated Myeloid Malignancies
Open the PDF for A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in <em>IDH1</em>-Mutated Myeloid Malignancies in another window
Includes: Supplementary data
Journal Articles

Abstract A50: Distinguishing Mosaic Li Fraumeni Syndrome, Clonal Hematopoiesis and Incidental Myeloid Neoplasms in Patients with Solid Tumors with Pathogenic TP53 Mutations Identified by Germline Testing or Cell-Free Circulating DNA Sequencing

Sanam Loghavi, Yoheved Gerstein, Mark J Routbort, Keyur P Patel, Koichi Takahashi, Molly Daniels, Julie Moskowitz, Danielle E Hammond, Kelly Chien, L. Jeffrey Medeiros, Farhad Ravandi, Hagop M Kantarjian, Guillermo Garcia-Manero, Banu Arun, Joseph D Khoury, Courtney D DiNardo
Journal: Blood Cancer Discovery
Blood Cancer Discov (2023) 4 (3_Supplement): A50.
https://doi.org/10.1158/2643-3249.AML23-A50
Published: 01 May 2023
View article titled, Abstract A50: Distinguishing Mosaic Li Fraumeni Syndrome, Clonal Hematopoiesis and Incidental Myeloid Neoplasms in Patients with Solid Tumors with Pathogenic TP53 Mutations Identified by Germline Testing or Cell-Free Circulating DNA Sequencing
Journal Articles

Patterns of Resistance Differ in Patients with Acute Myeloid Leukemia Treated with Type I versus Type II FLT3 Inhibitors

Ahmad S. Alotaibi, Musa Yilmaz, Rashmi Kanagal-Shamanna, Sanam Loghavi, Tapan M. Kadia, Courtney D. DiNardo, Gautam Borthakur, Marina Konopleva, Sherry A. Pierce, Sa A. Wang, Guilin Tang, Veronica Guerra, Bachar Samra, Naveen Pemmaraju, Elias Jabbour, Nicholas J. Short, Ghayas C. Issa, Maro Ohanian, Guillermo Garcia-Manero, Kapil N. Bhalla, Keyur P. Patel, Koichi Takahashi, Michael Andreeff, Jorge E. Cortes, Hagop M. Kantarjian, Farhad Ravandi, Naval Daver
Journal: Blood Cancer Discovery
Blood Cancer Discov (2021) 2 (2): 125–134.
https://doi.org/10.1158/2643-3230.BCD-20-0143
Published: 01 March 2021
View article titled, Patterns of Resistance Differ in Patients with Acute Myeloid Leukemia Treated with Type I versus Type II FLT3 Inhibitors
Open the PDF for Patterns of Resistance Differ in Patients with Acute Myeloid Leukemia Treated with Type I versus Type II FLT3 Inhibitors in another window